波士顿科学公司获得FDA批准Farmense心脏标测产品

2024-10-19 04:58

Boston Scientific (NYSE:BSX) said it has received FDA approval for its Farawave NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and Faraview software.
The products are used to provide visualization during pulsed field ablation, or PFA, procedures with the company's Farapulse PFA system.
The technologies are compatible with Boston Scientific’s existing cardiac mapping technology and its Opal HDx Mapping System. according to a statement.
Boston Scientific received FDA clearance for its Farapulse PFA System for the treatment of atrial fibrillation in January.

More on Boston Scientific